Gursharan K Sohi1, Jordan Levy2, Victoria Delibasic1, Laura E Davis1, Alyson L Mahar3, Elmira Amirazodi1, Craig C Earle4, Julie Hallet2, Ahmed Hammad5, Rajan Shah1, Nicole Mittmann6, Natalie G Coburn7. 1. Department of Evaluative Clinical Sciences, Sunnybrook Research Institute, Toronto, ON, Canada. 2. Division of General Surgery, Odette Cancer Centre, Sunnybrook Health Sciences Centre, 2075 Bayview Ave., Room T2 011, Toronto, ON, M4N 3M5, Canada. 3. Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada. 4. Division of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. 5. ICES, Toronto, ON, Canada. 6. Division of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. 7. Division of General Surgery, Odette Cancer Centre, Sunnybrook Health Sciences Centre, 2075 Bayview Ave., Room T2 011, Toronto, ON, M4N 3M5, Canada. natalie.coburn@sunnybrook.ca.
Abstract
PURPOSE: Cancer treatment is a significant driver of healthcare costs worldwide, however, the economic impact of treating patients with anti-neoplastic agents is poorly elucidated. We conducted a systematic review and meta-analysis to estimate the direct costs associated with administering intravenous chemotherapy in an outpatient setting. METHODS: We systematically searched four databases from 2010 to present and extracted hourly administration costs and the respective components of each estimate. Separate analyses were conducted of Canadian and United States (US) studies, respectively, to address a priori hypotheses regarding heterogeneity amongst estimates. The Drummond checklist was used to assess risk-of-bias. Data were summarized using medians with interquartile ranges and five outliers were identified; costs were presented in 2019 USD. RESULTS: Forty-four studies were analyzed, including sub-analyses of 19 US and seven Canadian studies. 26/44 studies were of moderate-high quality. When components of administration cost were evaluated, physician costs were reported most frequently (24 studies), followed by lab tests (13) and overhead costs (9). The median estimate (excluding outliers) was $142/hour (IQR = $103-166). The median administration cost in the US was $149/hour (IQR = $118-158), and was $128/hour (IQR = $102-137) in Canada. CONCLUSIONS: There is currently a paucity of literature addressing the costs of chemotherapy administration, and existing studies utilize a patchwork of reporting methodologies which renders direct comparison challenging. Our results demonstrate that the cost of administering chemotherapy is approximately $125-150/hour, globally. This value is dependent upon the region of analysis, inclusiveness of cost subcomponents as well as the methodology used to estimate unit prices, as described here.
PURPOSE:Cancer treatment is a significant driver of healthcare costs worldwide, however, the economic impact of treating patients with anti-neoplastic agents is poorly elucidated. We conducted a systematic review and meta-analysis to estimate the direct costs associated with administering intravenous chemotherapy in an outpatient setting. METHODS: We systematically searched four databases from 2010 to present and extracted hourly administration costs and the respective components of each estimate. Separate analyses were conducted of Canadian and United States (US) studies, respectively, to address a priori hypotheses regarding heterogeneity amongst estimates. The Drummond checklist was used to assess risk-of-bias. Data were summarized using medians with interquartile ranges and five outliers were identified; costs were presented in 2019 USD. RESULTS: Forty-four studies were analyzed, including sub-analyses of 19 US and seven Canadian studies. 26/44 studies were of moderate-high quality. When components of administration cost were evaluated, physician costs were reported most frequently (24 studies), followed by lab tests (13) and overhead costs (9). The median estimate (excluding outliers) was $142/hour (IQR = $103-166). The median administration cost in the US was $149/hour (IQR = $118-158), and was $128/hour (IQR = $102-137) in Canada. CONCLUSIONS: There is currently a paucity of literature addressing the costs of chemotherapy administration, and existing studies utilize a patchwork of reporting methodologies which renders direct comparison challenging. Our results demonstrate that the cost of administering chemotherapy is approximately $125-150/hour, globally. This value is dependent upon the region of analysis, inclusiveness of cost subcomponents as well as the methodology used to estimate unit prices, as described here.
Authors: Daniel E Abbott; Ryan P Merkow; Scott B Cantor; Jason B Fleming; Gauri R Varadhachary; Christopher Crane; David J Bentrem; Karl Y Bilimoria Journal: Ann Surg Oncol Date: 2012-09-11 Impact factor: 5.344
Authors: F Awan; S T Kochuparambil; D E Falconer; A Cumpston; S Leadmon; K Watkins; D Deremer; A Jillella; M Craig; M Hamadani Journal: Bone Marrow Transplant Date: 2013-04-15 Impact factor: 5.483
Authors: Daniel E Abbott; Ching-Wei David Tzeng; Ryan P Merkow; Scott B Cantor; George J Chang; Matthew Harold Katz; David J Bentrem; Karl Y Bilimoria; Christopher H Crane; Gauri R Varadhachary; James L Abbruzzese; Robert A Wolff; Jeffrey E Lee; Douglas B Evans; Jason B Fleming Journal: Ann Surg Oncol Date: 2013-02-10 Impact factor: 5.344
Authors: Anthony T Saxton; Dan Poenaru; Doruk Ozgediz; Emmanuel A Ameh; Diana Farmer; Emily R Smith; Henry E Rice Journal: PLoS One Date: 2016-10-28 Impact factor: 3.240